Cerner and CoverMyMeds team up for medication price transparency
The collaboration focuses on integrating patient-specific data into the EMR so providers can review prescription pricing information with patients.
The collaboration focuses on integrating patient-specific data into the EMR so providers can review prescription pricing information with patients.
With PriorAuthNow's fundraise to make a dent in the ginormous time-suck of prior authorization requests, here are four other companies trying to make a difference in this health IT subsector.
McKesson will pay about $1.1 billion, and an additional $270 million is contingent upon CoverMyMeds financial performance the next two years.
A new partnership with a company that bills itself as having the most broad-reaching healthcare communication network in the country could increase health IT startup CoverMyMeds‘ health insurance customer base. Cleveland-area CoverMyMeds (CMM) has developed Web-based tools that speed up and automate the submission of prior authorization requests to health insurance plans. Insurers sometimes require […]
A health IT startup dedicated to streamlining the prior authorization process has seen its physician user base explode in the last few months. CoverMyMeds (CMM) now has about 330,000 physician users completing prior authorization requests, up from about 130,000 in September, said Sam Rajan, principal and co-founder with the Cleveland-area company. CMM has developed Web- […]
Health IT firm CoverMyMeds has raised $1 million to continue developing its prior authorization technology. The fundraising has come over the course of about a year, with the largest investors being Cleveland venture development group JumpStart and Charles Hallberg, the founder of MemberHealth, a Solon, Ohio prescription drug coverage company that sold for $630 million […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
An Ohio board has approved a $546,055, seven-year tax credit for an expansion of CoverMyMeds LLC's Columbus office.
Healthcare technology and services company CoverMyMeds LLC has received a $250,000 investment commitment from JumpStart Ventures to develop its application for automated submission of requests to cover patient prescriptions that have been rejected by insurers. The Twinsburg, Ohio, company has developed Web- and phone-based tools that speed up and automate the submission of Prior Authorization […]